-
1
-
-
0029942573
-
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
-
Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, et al. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 1996; 40: 839-845.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 839-845
-
-
Zurenko, G.E.1
Yagi, B.H.2
Schaadt, R.D.3
Allison, J.W.4
Kilburn, J.O.5
Glickman, S.E.6
-
2
-
-
0002032644
-
Assessment of absolute bioavailability and evaluation of the effect of food on oral bioavailability of linezolid
-
Welshman IR, Stalker DJ, Wajszczuk CP. Assessment of absolute bioavailability and evaluation of the effect of food on oral bioavailability of linezolid (abstract). Anti-infect Drugs Chemother 1998; 16: 54.
-
(1998)
Anti-infect Drugs Chemother
, vol.16
, pp. 54
-
-
Welshman, I.R.1
Stalker, D.J.2
Wajszczuk, C.P.3
-
3
-
-
0033584879
-
Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center
-
Kloss P, Xiong L, Shinabarger DL, Mankin AS. Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J Mol Biol 1999; 294: 93-101.
-
(1999)
J Mol Biol
, vol.294
, pp. 93-101
-
-
Kloss, P.1
Xiong, L.2
Shinabarger, D.L.3
Mankin, A.S.4
-
4
-
-
0033631913
-
Linezolid, critical characteristics
-
Hamel JC, Stapert D, Moerman JK, Ford CW. Linezolid, critical characteristics. Infection 2000; 28: 60-64.
-
(2000)
Infection
, vol.28
, pp. 60-64
-
-
Hamel, J.C.1
Stapert, D.2
Moerman, J.K.3
Ford, C.W.4
-
5
-
-
0011970183
-
Chambers. Antimicrobial agents. Protein synthesis inhibitors and miscellaneous antibacterial agents
-
Joel G Hardman, Lee E Limbird (eds). New York, McGraw Hill
-
Henry F. Chambers. Antimicrobial agents. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Joel G Hardman, Lee E Limbird (eds). Goodman and Gilmans: The Pharmacological basis of therapeutics. New York, McGraw Hill 2001; 1239-1271.
-
(2001)
Goodman and Gilmans: The Pharmacological Basis of Therapeutics
, pp. 1239-1271
-
-
Henry, F.1
-
6
-
-
0036604489
-
Linezolid versus vancomycin for the treatment of methicillin resistant Staphylococcus aureus infections
-
Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin resistant Staphylococcus aureus infections. Clin Infect Dis 2002; 34: 1481-1490.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1481-1490
-
-
Stevens, D.L.1
Herr, D.2
Lampiris, H.3
Hunt, J.L.4
Batts, D.H.5
Hafkin, B.6
-
7
-
-
0242552187
-
Linezolid versus vancomycin: Analysis of two double blind studies of patients with MRSA nosocomial pneumonia
-
Wunderink RG, Rello J, Cammarata SK, Croos Dabrera RV, Kollof MH. Linezolid. versus vancomycin: Analysis of two double blind studies of patients with MRSA nosocomial pneumonia. Chest 2003; 124: 1789-1797.
-
(2003)
Chest
, vol.124
, pp. 1789-1797
-
-
Wunderink, R.G.1
Rello, J.2
Cammarata, S.K.3
Croos Dabrera, R.V.4
Kollof, M.H.5
-
8
-
-
1642451852
-
Linezolid for treatment of ventilator associated pneumonia: A cost effective alternative to vancomycin
-
Shorr AF, Susla GM, Kollef MH. Linezolid for treatment of ventilator associated pneumonia: A cost effective alternative to vancomycin. Crit Care Med 2004; 32: 137-143.
-
(2004)
Crit Care Med
, vol.32
, pp. 137-143
-
-
Shorr, A.F.1
Susla, G.M.2
Kollef, M.H.3
-
9
-
-
0035019692
-
-
Kaplan SL, Patterson L, Edwards KM, Azimi PH, Bradley JS, Blumer JL, et al. Pediatr Infect Dis J 2001; 20: 488-494.
-
(2001)
Pediatr Infect Dis J
, vol.20
, pp. 488-494
-
-
Kaplan, S.L.1
Patterson, L.2
Edwards, K.M.3
Azimi, P.H.4
Bradley, J.S.5
Blumer, J.L.6
-
11
-
-
0034221904
-
Compatibility screening of linezolid infection during simulated Y-site administration with other drugs and infusion solutions
-
Trissel LA, Williams KY, Gilbert DL. Compatibility screening of linezolid infection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000; 40: 515-519.
-
(2000)
J Am Pharm Assoc
, vol.40
, pp. 515-519
-
-
Trissel, L.A.1
Williams, K.Y.2
Gilbert, D.L.3
-
12
-
-
0034536035
-
Linezolid against penicillin sensitive and resistant pneumococci in the rabbit meningitis model
-
Cottagnoud P, Gerber CM, Acosta F, Cottagnoud M, Neftel K, Tauber MG. Linezolid against penicillin sensitive and resistant pneumococci in the rabbit meningitis model. J Antimicrob Chemother 2000; 46: 981-985.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 981-985
-
-
Cottagnoud, P.1
Gerber, C.M.2
Acosta, F.3
Cottagnoud, M.4
Neftel, K.5
Tauber, M.G.6
-
13
-
-
0035674984
-
Successful treatment of vancomycin resistant enterococcus meningitis with linezolid: Case report and review of literature
-
Steinmetz MP, Vogelbaum MA, De Georgi MA, Andrefsky JC, Isada C. Successful treatment of vancomycin resistant enterococcus meningitis with linezolid: Case report and review of literature. Crit Care Med 2001; 29: 2383-2385.
-
(2001)
Crit Care Med
, vol.29
, pp. 2383-2385
-
-
Steinmetz, M.P.1
Vogelbaum, M.A.2
De Georgi, M.A.3
Andrefsky, J.C.4
Isada, C.5
-
14
-
-
0035882189
-
Vancomycin resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of literature
-
Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of literature. Clin Infect Dis 2001; 33: 477-482.
-
(2001)
Clin Infect Dis
, vol.33
, pp. 477-482
-
-
Zeana, C.1
Kubin, C.J.2
Della-Latta, P.3
Hammer, S.M.4
|